Literature DB >> 14512066

A study of the psychometric properties of the Fagestrom Test for Nicotine Dependence.

Henri Chabrol1, Michel Niezborala, Evelyne Chastan, Jean Louis Montastruc, Etienne Mullet.   

Abstract

A factor analysis of 772 Fagestrom Test for Nicotine Dependence (FTND) was performed in a population of French workers with STATISTICA software, utilizing tetrachoric correlations to account for the dichotomous responses of the FTND. Confirmatory factorial analysis found the two-factor solution recently proposed for the FTND to be unsatisfactory. An exploratory factorial analysis concluded that the best solution was monofactorial when Item 3 was deleted. A confirmatory factorial analysis of the FTND provided support for this monofactorial solution. With the deletion of Item 3, the FTND achieved a high internal consistency (Cronbach's alpha=.86). Thus, a revision of the FTND with the exclusion of Item 3 is proposed. This revised form of the FTND appears to assess a unidimensional construct indicating robust construct validity.

Entities:  

Mesh:

Year:  2003        PMID: 14512066     DOI: 10.1016/s0306-4603(02)00236-8

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  11 in total

1.  A Comparison of the Fagerström Test for Cigarette Dependence and Cigarette Dependence Scale in a Treatment-Seeking Sample of Pregnant Smokers.

Authors:  Ivan Berlin; Edward G Singleton; Stephen J Heishman
Journal:  Nicotine Tob Res       Date:  2015-05-19       Impact factor: 4.244

2.  Gender Differences in the Fagerström Test for Nicotine Dependence in Korean Americans.

Authors:  Sun S Kim; Hua Fang; Joseph Difranza; Douglas M Ziedonis; Grace X Ma
Journal:  J Smok Cessat       Date:  2012-07-13

3.  An examination of the Fagerström Test for Nicotine Dependence among concurrent tobacco and khat users.

Authors:  Motohiro Nakajima; Mustafa al'Absi; Anisa Dokam; Mohammed Alsoofi; Najat Sayem Khalil
Journal:  J Psychoactive Drugs       Date:  2012 Nov-Dec

4.  CHRNA5/A3/B4 Variant rs3743078 and Nicotine-Related Phenotypes: Indirect Effects Through Nicotine Craving.

Authors:  Dvora Shmulewitz; Jacquelyn L Meyers; Melanie M Wall; Efrat Aharonovich; Amos Frisch; Baruch Spivak; Abraham Weizman; Howard J Edenberg; Joel Gelernter; Deborah S Hasin
Journal:  J Stud Alcohol Drugs       Date:  2016-03       Impact factor: 2.582

Review 5.  Genetics of nicotine dependence and pharmacotherapy.

Authors:  Christina N Lessov-Schlaggar; Michele L Pergadia; Taline V Khroyan; Gary E Swan
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

6.  Propofol sedation during gastrointestinal endoscopy arouses euphoria in a large subset of patients.

Authors:  Thorsten Brechmann; Christoph Maier; Miriam Kaisler; Jan Vollert; Wolff Schmiegel; Svetlana Pak; Norbert Scherbaum; Fred Rist; Andrea Riphaus
Journal:  United European Gastroenterol J       Date:  2017-10-04       Impact factor: 4.623

7.  Clarifying the Genetic Influences on Nicotine Dependence and Quantity of Use in Cigarette Smokers.

Authors:  Brad Verhulst; Shaunna L Clark; Jingchun Chen; Hermine H Maes; Xiangning Chen; Michael C Neale
Journal:  Behav Genet       Date:  2021-04-21       Impact factor: 2.965

8.  Real-world comparative study of behavioral group therapy program vs education program implemented for smoking cessation in community-dwelling elderly smokers.

Authors:  Chaicharn Pothirat; Nittaya Phetsuk; Chalerm Liwsrisakun; Athavudh Deesomchok
Journal:  Clin Interv Aging       Date:  2015-04-13       Impact factor: 4.458

9.  Correlation between nicotine dependence and barriers to cessation between exclusive cigarette smokers and dual (water pipe) smokers among Arab Americans.

Authors:  Omar El-Shahawy; Linda Haddad
Journal:  Subst Abuse Rehabil       Date:  2015-01-30

10.  Psychological adaptation of Indian expeditioners during prolonged residence in Antarctica.

Authors:  Sudhir K Khandelwal; Abhijeet Bhatia; Ashwani K Mishra
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.